Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.43 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.41 |
| ▸ | GMNN | O75496 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | THPO | P40225 | 1/20 | 0.41 |
| ▸ | MTOR | P42345 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CETP | P11597 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | UBE2N | P61088 | 1/20 | 0.41 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8407962 | 1.00 | GPR84 (0.43) | GPR84SPHK1FFAR1LMNAMAPT | |
| SCHEMBL28219342 | 1.00 | GPR84 (0.43) | GPR84SPHK1FFAR1LMNAMAPT | |
| SCHEMBL11554779 | 1.00 | GPR84 (0.43) | GPR84SPHK1FFAR1LMNAMAPT | |
| SCHEMBL21066248 | 0.98 | GPR84 (0.40) | GPR84SPHK1FFAR1LMNAMAPT | |
| SCHEMBL9408555 | 0.90 | GPR84 (0.39) | GPR84SPHK1FFAR1LMNAMAPT | |
| SCHEMBL9408559 | 0.90 | GPR84 (0.39) | GPR84SPHK1FFAR1LMNAMAPT | |
| SCHEMBL22116285 | 0.88 | GPR84 (0.38) | GPR84SPHK1FFAR1LMNAMAPT | |
| SCHEMBL7539369 | 0.86 | GPR84 (0.37) | GPR84SPHK1FFAR1LMNAMAPT | |
| SCHEMBL4840528 | 0.86 | GPR84 (0.37) | GPR84SPHK1FFAR1LMNAMAPT | |
| SCHEMBL7547415 | 0.86 | GPR84 (0.37) | GPR84SPHK1FFAR1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4700017-A2 | FLUORINATED CATIONIC LIPIDS FOR USE IN LIPID NANOPARTICLES | Acuitas Therapeutics Inc. (CA) | 2026-02-25 | — | — | EP | disclosed |
| EP-4448486-B1 | FLUORINATED CATIONIC LIPIDS FOR USE IN LIPID NANOPARTICLES | ACUITAS THERAPEUTICS INC (CA) | 2025-10-15 | — | — | EP | disclosed |
| US-20250092002-A1 | FLUORINATED CATIONIC LIPIDS FOR USE IN LIPID NANOPARTICLES | ACUITAS THERAPEUTICS INC (CA) | 2025-03-20 | — | — | US | disclosed |
| US-20250059131-A1 | FLUORINATED CATIONIC LIPIDS FOR USE IN LIPID NANOPARTICLES | ACUITAS THERAPEUTICS INC (CA) | 2025-02-20 | — | — | US | disclosed |
| EP-4448486-A1 | FLUORINATED CATIONIC LIPIDS FOR USE IN LIPID NANOPARTICLES | Acuitas Therapeutics, Inc. (CA) | 2024-10-23 | — | — | EP | disclosed |
| EP-4448482-A2 | FLUORINATED CATIONIC LIPIDS FOR USE IN LIPID NANOPARTICLES | Acuitas Therapeutics, Inc. (CA) | 2024-10-23 | — | — | EP | disclosed |
| WO-2023114944-A1 | FLUORINATED CATIONIC LIPIDS FOR USE IN LIPID NANOPARTICLES | Acuitas Therapeutics, Inc. (CA) | 2023-06-22 | — | — | WO | disclosed |
| WO-2023114944-A1 | FLUORINATED CATIONIC LIPIDS FOR USE IN LIPID NANOPARTICLES | Acuitas Therapeutics, Inc. (CA) | 2023-06-22 | — | — | WO | disclosed |
| WO-2023114937-A2 | FLUORINATED CATIONIC LIPIDS FOR USE IN LIPID NANOPARTICLES | Acuitas Therapeutics, Inc. (CA) | 2023-06-22 | — | — | WO | disclosed |
| WO-2023114937-A2 | FLUORINATED CATIONIC LIPIDS FOR USE IN LIPID NANOPARTICLES | Acuitas Therapeutics, Inc. (CA) | 2023-06-22 | — | — | WO | disclosed |
| US-10295487-B2 | In situ NMR parameter monitoring systems and methods for measuring pH and temperature | THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 2019-05-21 | — | — | US | disclosed |
| US-10067079-B2 | Solid state NMR spectroscopy/imaging in situ measuring devices and methods for calibration and determining one or more quantitative properties of a target sample | THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 2018-09-04 | — | — | US | disclosed |
| WO-2017083665-A1 | SOLID STATE NMR SPECTROSCOPY/IMAGING IN SITU MEASURING DEVICES | THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 2017-05-18 | — | — | WO | disclosed |
| US-20160109390-A1 | In Situ NMR Parameter Monitoring Systems and Methods for Measuring PH and Temperature | THE CURATORS OF THE UNIVERSITY OF MISSOURI | 2016-04-21 | — | — | US | disclosed |
| US-20160109391-A1 | SOLID STATE NMR SPECTROSCOPY/IMAGING IN SITU MEASURING DEVICES AND METHODS FOR CALIBRATION AND DETERMINING ONE OR MORE QUANTITATIVE PROPERTIES OF A TARGET SAMPLE | THE CURATORS OF THE UNIVERSITY OF MISSOURI | 2016-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250059131-A1 | FLUORINATED CATIONIC LIPIDS FOR USE IN LIPID NANOPARTICLES | PHOSPHO1, NPC1, SGMS1 | GPR84 2773/4885SPHK1 322/4885FFAR1 82/4885 |
| US-20250092002-A1 | FLUORINATED CATIONIC LIPIDS FOR USE IN LIPID NANOPARTICLES | PHOSPHO1, LPAR3, RFTN1 | GPR84 1519/4885SPHK1 476/4885FFAR1 97/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.